{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:34:40Z","timestamp":1794648880589,"version":"4.9.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Marie Curie Intra-European Fellowship (Proposal","award":["624871"],"award-info":[{"award-number":["624871"]}]},{"name":"NWO VENI","award":["91919149"],"award-info":[{"award-number":["91919149"]}]},{"name":"Gravitation","award":["2013 ICI-024.002.009"],"award-info":[{"award-number":["2013 ICI-024.002.009"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>SSc is a complex disease characterized by vascular abnormalities and inflammation culminating in hypoxia and excessive fibrosis. Previously, we identified chemokine (C-X-C motif) ligand 4 (CXCL4) as a novel predictive biomarker in SSc. Although CXCL4 is well-studied, the mechanisms driving its production are unclear. The aim of this study was to elucidate the mechanisms leading to CXCL4 production.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Plasmacytoid dendritic cells (pDCs) from 97 healthy controls and 70 SSc patients were cultured in the presence of hypoxia or atmospheric oxygen level and\/or stimulated with several toll-like receptor (TLR) agonists. Further, pro-inflammatory cytokine production, CXCL4, hypoxia-inducible factor (HIF) -1\u03b1 and HIF-2\u03b1 gene and protein expression were assessed using ELISA, Luminex, qPCR, FACS and western blot assays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CXCL4 release was potentiated only when pDCs were simultaneously exposed to hypoxia and TLR9 agonist (P\u2009&amp;lt;\u20090.0001). Here, we demonstrated that CXCL4 production is dependent on the overproduction of mitochondrial reactive oxygen species (mtROS) (P\u2009=\u20090.0079) leading to stabilization of HIF-2\u03b1 (P\u2009=\u20090.029). In addition, we show that hypoxia is fundamental for CXCL4 production by umbilical cord CD34 derived pDCs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>TLR-mediated activation of immune cells in the presence of hypoxia underpins the pathogenic production of CXCL4 in SSc. Blocking either mtROS or HIF-2\u03b1 pathways may therapeutically attenuate the contribution of CXCL4 to SSc and other inflammatory diseases driven by CXCL4.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab532","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T19:16:01Z","timestamp":1631819761000},"page":"2682-2693","source":"Crossref","is-referenced-by-count":25,"title":["Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2\u03b1"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-3968","authenticated-orcid":false,"given":"Andrea","family":"Ottria","sequence":"first","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maili","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent M","family":"Paardekooper","sequence":"additional","affiliation":[{"name":"Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-2288","authenticated-orcid":false,"given":"Tiago","family":"Carvalheiro","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Vazirpanah","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Silva-Cardoso","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0859-2322","authenticated-orcid":false,"given":"Alsya J","family":"Affandi","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Chouri","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"v.d Kroef","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph G","family":"Tieland","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis P J","family":"Bekker","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina G K","family":"Wichers","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Rossato","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Mocholi-Gimeno","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Tekstra","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Ton","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap M","family":"van Laar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cossu","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6529-6258","authenticated-orcid":false,"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[{"name":"Referral Center for Systemic Autoimmune Diseases, University of Milan & Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Garcia Perez","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aridaman","family":"Pandit","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Bonte-Mineur","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Maasstad Hospital , Rotterdam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris A","family":"Reedquist","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"van den Bogaart","sequence":"additional","affiliation":[{"name":"Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, the Netherlands"},{"name":"Department of Molecular Immunology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen , Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R D J","family":"Radstake","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioleta","family":"Marut","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology"},{"name":"Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht University , Utrecht"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"2022060107570637600_keab532-B1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"2022060107570637600_keab532-B2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/ITT.S82037","article-title":"Current perspectives on the immunopathogenesis of systemic sclerosis","volume":"5","author":"Fuschiotti","year":"2016","journal-title":"Immunotargets Ther"},{"key":"2022060107570637600_keab532-B3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"key":"2022060107570637600_keab532-B4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/eji.200939703","article-title":"CXCL4-induced monocyte survival, cytokine expression, and oxygen radical formation is regulated by sphingosine kinase 1","volume":"40","author":"Kasper","year":"2010","journal-title":"Eur J Immunol"},{"key":"2022060107570637600_keab532-B5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood.V95.4.1158.004k31_1158_1166","article-title":"The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages","volume":"95","author":"Scheuerer","year":"2000","journal-title":"Blood"},{"key":"2022060107570637600_keab532-B6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/eji.201747195","article-title":"CXCL4 is a novel inducer of human Th17 cells and correlates with IL-17 and IL-22 in psoriatic arthritis","volume":"48","author":"Affandi","year":"2018","journal-title":"Eur J Immunol"},{"key":"2022060107570637600_keab532-B7","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jaci.2005.09.035","article-title":"CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production","volume":"116","author":"Romagnani","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"2022060107570637600_keab532-B8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","article-title":"CXCR3 ligands in disease and therapy","volume":"26","author":"Van Raemdonck","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"2022060107570637600_keab532-B9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2332\/allergolint.O-08-537","article-title":"Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of \u03b2-thromboglobulin and platelet factor 4","volume":"57","author":"Tamagawa-Mineoka","year":"2008","journal-title":"Allergol Int"},{"key":"2022060107570637600_keab532-B10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/annrheumdis-2014-206921","article-title":"Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis","volume":"75","author":"Yeo","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022060107570637600_keab532-B11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005176-200308000-00019","article-title":"Plasma markers of platelet activation in cystic fibrosis liver and lung disease","volume":"37","author":"Schwarz","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2022060107570637600_keab532-B12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2141.1984.tb02912.x","article-title":"Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis","volume":"57","author":"Burstein","year":"1984","journal-title":"Br J Haematol"},{"key":"2022060107570637600_keab532-B13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/hep.23435","article-title":"CXC chemokine ligand 4 (CXCl4) is a platelet-derived mediator of experimental liver fibrosis","volume":"51","author":"Zaldivar","year":"2010","journal-title":"Hepatology"},{"key":"2022060107570637600_keab532-B14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front Immunol"},{"key":"2022060107570637600_keab532-B15","doi-asserted-by":"crossref","first-page":"eaam8458","DOI":"10.1126\/scitranslmed.aam8458","article-title":"Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8","volume":"10","author":"Kioon","year":"2018","journal-title":"Sci Transl Med"},{"key":"2022060107570637600_keab532-B16","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022060107570637600_keab532-B17","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies","volume":"20","author":"Clements","year":"1993","journal-title":"J Rheumatol"},{"key":"2022060107570637600_keab532-B18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2022060107570637600_keab532-B19","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2022060107570637600_keab532-B20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2022060107570637600_keab532-B21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"2022060107570637600_keab532-B22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2022060107570637600_keab532-B23","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.8066449","article-title":"Generation of lymphohematopoietic cells from embryonic stem cells in culture","volume":"265","author":"Nakano","year":"1994","journal-title":"Science"},{"key":"2022060107570637600_keab532-B24","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial Complex III stabilize hypoxia-inducible factor-1\u03b1 during hypoxia: a mechanism of O2 sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"J Biol Chem"},{"key":"2022060107570637600_keab532-B25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.RES.88.5.529","article-title":"Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction","volume":"88","author":"Ide","year":"2001","journal-title":"Circ Res"},{"key":"2022060107570637600_keab532-B26","doi-asserted-by":"crossref","first-page":"e10983","DOI":"10.1371\/journal.pone.0010983","article-title":"Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1\u03b1 and dendritic cell maturation under normoxic conditions","volume":"5","author":"Spirig","year":"2010","journal-title":"PLoS One"},{"key":"2022060107570637600_keab532-B27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/ar2598","article-title":"Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis","volume":"11","author":"Beyer","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2022060107570637600_keab532-B28","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3389\/fimmu.2020.02149","article-title":"CXCL4 links inflammation and fibrosis by reprogramming monocyte-derived dendritic cells in vitro","volume":"11","author":"Silva-Cardoso","year":"2020","journal-title":"Front Immunol"},{"key":"2022060107570637600_keab532-B29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4049\/jimmunol.1602020","article-title":"CXCL4 exposure potentiates TLR-driven polarization of human monocyte-derived dendritic cells and increases stimulation of T cells","volume":"199","author":"Silva-Cardoso","year":"2017","journal-title":"J Immunol"},{"key":"2022060107570637600_keab532-B30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front Immunol"},{"key":"2022060107570637600_keab532-B31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.18632\/oncotarget.26608","article-title":"Oxygen in the tumor microenvironment: effects on dendritic cell function","volume":"10","author":"Paardekooper","year":"2019","journal-title":"Oncotarget"},{"key":"2022060107570637600_keab532-B32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-8722-6-19","article-title":"Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers","volume":"6","author":"Li","year":"2013","journal-title":"J Hematol Oncol"},{"key":"2022060107570637600_keab532-B33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.redox.2017.07.016","article-title":"Regulation of type I interferon responses by mitochondria-derived reactive oxygen species in plasmacytoid dendritic cells","volume":"13","author":"Agod","year":"2017","journal-title":"Redox Biol"},{"key":"2022060107570637600_keab532-B34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/ars.2012.4800","article-title":"Why mitochondria must fuse to maintain their genome integrity","volume":"19","author":"Vidoni","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"2022060107570637600_keab532-B35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.fct.2015.03.020","article-title":"Sulforaphane protects against acetaminophen-induced hepatotoxicity","volume":"80","author":"Noh","year":"2015","journal-title":"Food Chem Toxicol"},{"key":"2022060107570637600_keab532-B36","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"2022060107570637600_keab532-B37","doi-asserted-by":"crossref","first-page":"L922","DOI":"10.1152\/ajplung.00014.2002","article-title":"Hypoxic but not anoxic stabilization of HIF-1\u03b1 requires mitochondrial reactive oxygen species","volume":"283","author":"Schroedl","year":"2002","journal-title":"Am J Physiol Cell Mol Physiol"},{"key":"2022060107570637600_keab532-B38","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.febslet.2005.03.088","article-title":"A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1\u03b1","volume":"579","author":"Sanju\u00e1n-Pla","year":"2005","journal-title":"FEBS Lett"},{"key":"2022060107570637600_keab532-B39","doi-asserted-by":"crossref","first-page":"e1001881","DOI":"10.1371\/journal.pbio.1001881","article-title":"Hypoxia-inducible factor-2\u03b1 is an essential catabolic regulator of inflammatory rheumatoid arthritis","volume":"12","author":"Ryu","year":"2014","journal-title":"PLoS Biol"},{"key":"2022060107570637600_keab532-B40","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.117.10787","article-title":"Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults","volume":"71","author":"Rossman","year":"2018","journal-title":"Hypertension"},{"key":"2022060107570637600_keab532-B41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1200\/JCO.2017.74.2627","article-title":"Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2\u03b1 antagonist in patients with previously treated advanced clear cell renal cell carcinoma","volume":"36","author":"Courtney","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab532\/41743081\/keab532.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/6\/2682\/43891878\/keab532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/6\/2682\/43891878\/keab532.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T08:00:17Z","timestamp":1654070417000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/6\/2682\/6374904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,9,24]]},"published-print":{"date-parts":[[2022,5,30]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab532","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2021,9,24]]}}}